Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1997-3-10
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0007-1226
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
50
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
69-70
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9038519-Adult,
pubmed-meshheading:9038519-Animals,
pubmed-meshheading:9038519-Burns,
pubmed-meshheading:9038519-Epoprostenol,
pubmed-meshheading:9038519-Graft Survival,
pubmed-meshheading:9038519-Humans,
pubmed-meshheading:9038519-Male,
pubmed-meshheading:9038519-Platelet Aggregation Inhibitors,
pubmed-meshheading:9038519-Rats,
pubmed-meshheading:9038519-Surgical Flaps
|
pubmed:year |
1997
|
pubmed:articleTitle |
Beraprost sodium: a stable prostaglandin I2 analogue.
|
pubmed:publicationType |
Letter,
Comment
|